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1. Introduction 
Xanthothricin (toxoflavin) represents a new class 
of antibiotics based on 1,6-dimethyl-5,7-dioxo-1,5,6,7- 
tetrahydropyrimido-(5,4-e)as-triazin [ 11, it possesses 
a broad spectrum of antibacterial, anticancer and toxic 
effects [2,3]. 
There is only one publication [4] showing that this 
antibiotic stimulates endogenous respiration of homo- 
genates and cultures of yeast and other microorganisms 
and that it abolishes the effects of the inhibitors of 
electron transfer, antimycin A and cyanide. The oxi- 
dation of added NADH in the presence of xantho- 
thricin caused the formation of HzOz. 
From their data the authors concluded that the 
antibiotic was shunting the respiratory chain, oxidizing 
NADH with the formation of HzOz, the latter causing 
the antibiotic activity and toxic effect of this comnound 
]4] * 
In our opinion existing data are insufficient o 
prove the proposed mechanism. Further Hz& is a 
normal cell metabolite [S] so its formation cannot 
explain xanthothricin’s biological activity. 
In the present paper data on the effects of xantho- 
tricin on the respiratory chain in yeast mitochondria, 
rat-liver mitochondria nd intact Ehrlich ascites 
tumour cells are reported. These preparations were 
chosen to cover all the three aspects of xantho- 
thricin’s effects. 
2. Methods 
Rat-liver mitochondria were isoIated by Schneider’s 
~orth~~o~~nd Publishing Company - Amsterdam 
method [6]. Yeast mitochondria were isolated from 
Candida ~i~o~y&ica [7]. Ehrlich ascites tumour cells 
were obtained by the method of Galeotti et al. [SJ. 
Mitochondrial respiratory rate was determined 
with an LP-7 polarograph provided with a closed 
Clark-type platinum electrode. The respiratory medium 
contained, for rat-liver mitochondria, 0.25 M sucrose, 
5 mM potassium phosphate, 5mM MgSO4,O.l mM 
EDTA, pH 7.5; for yeast mitochondria, 0.65 M 
mannite, 0.05% bovine serum albumin, 0.3 mM 
EDTA, 10 mM Tris-phosphate, pH 7.0; for ascites 
cells, 154 mM NaCf ,6.2 mM KCl, 11 mM phosphate 
buffer, pH 7.5. Sample volume, 2 ml. Room tempera- 
ture, 22-25°C. 
The degree of reduction of pyridine nucleotides was 
determined by their fluorescence at 460 nm. Incuba- 
tion was in respiratory medium. 
ATPase activity of rat-liver mitochondria was 
determined by measuring the acidi~cation of the 
incubation medium with an LPI-l-01 pH-meter 
coupled to an automatic KSP-4 potentiometer 191. 
The incubation medium contained 0.25 M sucrose, 
2 mM potassium phosphate, 50 mM KCl, pH 7.5. 
Sample volume, 4 ml. Room temperature, 22-25°C. 
Protein in mitochondria nd cells was determined by 
the biuret method [ 1 O] . 
3. Results 
Measurements of respiratory rate of animal and 
yeast mitochondria in the presence of varying amounts 
of added xanthothricin showed a maximal stimulation 
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Fig. 1. Effect of xanthothricin on oxidation of NAD-linked substrates and NADH. Additions: rat liver mitochondria 2-3 mg pro- 
-tein/ml; yeast mitochondria (Y.mito) 0.75 mg/ml; 5 mM a-oxoglutarate; 1 mM NADH; 10 PM rotenone; 1 pg/ml antimycin A; 
1 mM cyanide; 1 mM arsenite; 10 pM xanthothricin. 
at 10 PM antibiotic. Further increase of xanthothricin 
concentration did not increase the rate of oxygen 
consumption. Therefore all further measurements 
were made with 10 PM xanthothricin. 
The effect of xanthothricin on oxidation of NAD- 
linked substrates and NADH is shown in fig. 1, which 
shows that the antibiotic not only removes the inhibi- 
tory effects of rotenone, antimycin A and cyanide but 
stimulates mitochondrial respiration 2-3 times when 
oxidizing cr-oxoglutarate (curve A). Addition of these 
inhibitors after xanthothricin does not remove the 
latter’s stimulating effect, even increasing it slightly 
(curve B). On the contrary, arsenite entirely removes 
the xanthothricin effect (curve D) and, when added 
after arsenite, xanthothricin has no effect (curve C). 
Oxidation of exogenous NADH by yeast mitochondria 
is also stimulated by xanthothricin (curve E), the 
extent of stimulation being greater than with (Y- 
oxoglutarate. These results allow one to suppose that 
xanthothricin transfers the reducing equivalents from 
NADH-dehydrogenase to oxygen, by-passing the 
respiratory chain. 
We then studied the effect of xanthothricin on suc- 
cinate oxidation (fig. 2). This figure shows that xantho- 
thricin stimulates succinate oxidation but that malon- 
ate, antimycin A and cyanide still completeley inhibit 
respiration (curve B). When xanthothricin is added 
after these inhibitors it does not stimulate respiration 
(curve A). It is important to notice that though rote- 
none does not inhibit succinate oxidation, it prevents 
the stimulating effect of xanthothricin (curve C) and 
addition of rotenone after xanthothricin prevents the 
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Fig. 2. Effect of xanthothricin on succiuate oxidation. Additions: rat liver initochondria 2-3 mg protein/ml; yeast mitochondria 
(Y.mito) 1.25 mg protein/ml. 5 mM succinate, 5 mM malonate, 1&/ml antimycin A, 1 mM cyanide, IO PM rotenone, 10 PM 
xanthothricin. 
latter’s timtiatory effect (curve D). Succinate oxida- 
tion by yeast mitochondria is also stimulated by xantho- 
thricin (curve E) but the respiratory increase is less than 
with rat-liver mitochondria. 
Xanthothricin has no effect on ATPase activity. 
The effect of xanthothricin on intact Ehrlich 
ascites tumour cells is almost he same as on mitochon- 
dria, but for maximal activity a concentration of 
about 300 &I is needed. This may be explained by 
the additions barrier to penetration of x~~o~icin 
which the cytoplasmic membrane offers. 
4. Discussion 
The present results how that xanthothricin re- 
moves the effect of rotenone in repressing the 
oxidation of NADH-dehydrogenase but not that of 
arsenite in inhibiting NAD reduction by cr-oxogluta- 
rate (fig. 1, curves A and C). On the other hand, 
xanthothricin prevents the inhibition of cY-oxogluta- 
rate oxidation by rotenone but not by arsenite (curves 
B and D). Thus xanthothricin by-passes the rotenone- 
sensitive site in the respiratory chain. As xanthothricin 
does not directly oxidize NADH and as its redox poten- 
tiai, 0.049 V [ 11 J, is near to that of NADH-dehydro- 
genase, one may suppose that xanthothricin accepts 
electrons at the level of N~H-del~ydrogenase. The 
insensitivity of respiration to antimycin A and cya- 
nide in the presence of xanthothricin (fig. 1, curves A 
and B) demonstrates the shunting of the wole respira- 
tory chain from NADH-dehydrogenase to oxygen by 
this antibiotic. 
Fig. 1 also shows that xanthothricin considerably 
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stimulates the oxidation of exogenous NADH by yeast 
mitochondria (curve E). The antibiotic increases the 
rate of oxidation of NAD-linked substrates 2-3 times 
but the rate of exogenous NADH oxidation is increas- 
ed 15-20 times. This great difference may probably 
be explained either by the readier availability of the 
dehydrogenase oxidizing exogenous NADH, which is 
on the outer side of the inner mitochondrial mem- 
brane [ 121, or by the greater affinity for xantho- 
thricin of the ‘exogenous’ rather than the ‘endogenous’ 
NADH-dehydrogenase. 
Xanthothricin also stimulates mitochondrial 
respiration during succinate oxidation but, as follows 
from fig. 2, this is due to reversed electron transfer to 
NAD and then via xanthothricin to oxygen and not 
by the oxidation of succinate dehydrogenase by the 
antibiotic. Xanthothricin does not alter the effects of 
the inhibitors of succinate oxidation, malonate, anti- 
mycin A and cyanide (curves A and B). Rotenone, 
which does not inhibit succinate oxidation but does 
inhibit reversed electron flow from succinate, pre- 
vents the xanthothricin effect (curve C) and decreas- 
es respiration to the former level (curve D). A 
considerably smaller xanthothricin effect in yeast 
rotenone, CH- Xanthotbricin rotenoqe, CI- xan~hothricin 
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Fig. 3. Effect of xanthothricin on the degree of reduction of pyridine nucleotides in mitochondria. Additions: rat-liver mitochon- 
dria (R.L.mito) 2.4 mg protein/ml; yeast mitochondria (Y.mito) 2.6 mg protein/ml; 5 mM a-oxoglutarate, 5 mM succinate; 10 MM 
rotenone; 1 mM cyanide; 200 PM ADP; 1 PM FCCP; 10 J.IM xanthothricin. 
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mitochondria oxidizing succinate (curve E), may 
probably be explained by the lower intensity of 
reverse electron transfer in yeast than in rat-liver 
mitochondria. 
The polarographic data are confirmed by the data 
obtained by fluorometry of pyridine nucleotides 
(fig. 3). Curves A and B show that the presence of 
rotenone or cyanide does not prevent the oxidation 
by xanthothricin of pyridine nucleotides reduced by 
an NAD-linked substrate or by succinate. Phospho- 
rylation during oxidation of NAD-linked substrates 
in the presence of xanthothricin is absent (curve C) 
a(-oxoglutarate 
n J 
s s 
A= araenlte 
FP 
19 
-Ilgdroqbutyrate / IUD+ 
I 
1 
F . Fe 
P nh 
I== 
rotenone 
cyt.b 
KcQ-PP. Peti 
I -T 
enccinate 
malonate 
Xanthotbrlcin 
I+= 
mtimycin A 
cyt.0, 
I 
0yt.C 
I 
cgt . aa3N KCB 
-1 2 
Fig. 4. Scheme showing the effect of xanthothricin on the electron transport chain of mitochondria. 
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as xanthothricin shunts all three coupling sites. 
During succinate oxidation in the presence of xantho- 
thricin phosphorylation does take place though its 
efficiency is decreased (curves D and F). This may 
probably be explained by supposing that the macro- 
ergic compounds formed are used to support reversed 
electron transfer. During succinate oxidation by yeast 
mitochondria, xanthothricin completely oxidizes 
pyridine nucleotides (curve E), which is probably 
connected with the low rate of reversed electron 
transfer. 
Preservation of oxidative phosphorylation during 
succinate oxidation in the presence of xanthothricin 
and an absence of an effect of this antibiotic on 
ATPase activity suggests that xanthothricin has no 
effect on the energy transfer chain or on the cou- 
pling sites. 
From the data presented one may conclude that 
xanthothricin is a specific carrier of reducing equiva- 
lents from NADH-dehydrogenase to oxygen (fig. 4). 
Xanthothricin prevents phosphorylation during 
oxidation of NAD-linked substrates and reduces its 
efficiency during succinate oxidation. Being unregu- 
lated by the respiratory chain, NADH oxidation by 
xanthothricin leads to a decrease of the reduced 
pyridine nucleotide pool and of the pool of macro- 
ergic compounds both of which are necessary for 
normal cell metabolism particularly for protein 
synthesis. This probably explains its antibiotic 
activity, toxicity and anticancer effect. 
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